Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT05612672

Evaluation of GeoHAI Implementation

Geographic Information Systems (GIS) and spatial analysis have become important tools in public health informatics but have rarely been applied to the hospital setting. In this study we apply these tools to address the challenge of Hospital Acquired Infections (HAIs) by building, implementing, and evaluating a new computer application which incorporates mapping and geographic data to assist hospital epidemiologists in identifying HAI clusters and assessing transmission risk. We expect that incorporation of geographic information into the workflow of hospital epidemiologists will have a profound effect on our understanding of disease transmission and HAI risk factors in the hospital setting, radically altering the workflow and speed of response of infection preventionists and improving their ability to prevent HAIs.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The Ohio State University

Columbus, Ohio, 43210, United States

About this study

Hospital Acquired Infections are common, affecting 3.2% of acute care hospital admissions. Recent reports have shown an improvement in overall HAI rates, primarily driven by improvements in surgical site (SSI) and catheter associated urinary tract infections (CAUTI). Transmissible infections, such as Clostridium difficile (CDI), have not shown the same decrease over time. This may be because prevention of CDI requires a comprehensive hospital-wide approach addressing environmental and patient-level risk factors. Geographic Information Systems (GIS) and spatial analysis techniques have become an important tool in public health informatics because they can integrate a vast number of data sources and explore associations and patterns in the data not visible using traditional biostatistical methods. Applications of GIS and spatial analysis are wide ranging but have largely been ignored in the hospital setting. The objective of this research is to develop a HAI assessment tool, which incorporates geographic data on the hospital and patient-level data from the electronic health record system, that is useful for hospital infection preventionists in better identifying clusters of HAI and assessing potential risk. We bring together a multidisciplinary team of clinical, operational, and academic investigators with expertise in GIS and spatial analysis, patient safety, public health informatics, usability assessment, and mixed- methods evaluation. As part of a larger study, this aim will seek to implement a GeoHAI tool that uses spatio-temporal Bayesian models to identify clusters of NHSN-defined hospital onset CDI and multidrug resistant organisms (MDRO) and predict potential high risk areas given hospital and patient risk factors. Unique to our approach is an evaluation strategy that focuses on the reduction of hospital acquired infection, but also seeks to understand how the tool and the information derived from the tool impacts patient safety practices in the hospital. We expect the implementation of this tool to radically change the workflow and speed of response of infection preventionists, greatly improving their ability to prevent HAI instead of reacting after they have occurred.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Infection preventionist or physician involved in infection prevention at participating health system

Exclusion criteria

  • Not an infection preventionist nor a physician involved in infection prevention
  • Does not work at the participating health system

Treatment and study plan

GeoHAI

Other

A Geographic healthcare-associated infection (HAI) visualization and assessment tool (GeoHAI) which uses spatio-temporal Bayesian models to identify clusters of National Healthcare Safety Network (NHSN)-defined hospital onset Clostridium difficile (CDI) and multidrug resistant organisms (MDRO), and predict potential high risk areas given hospital and patient risk factors.

Primary outcomes

  1. Change from Baseline Healthcare-Associated Infection (HAI) Rate

    Time frame: Baseline and 3 months post-implementation

    HAI rate at healthcare system level before intervention and after

Secondary outcomes

  1. Knowledge of tool

    Time frame: Immediately post-training

    Knowledge questions to assess understanding of how to use the GeoHAI tool, assessed after participants are trained on how to use the tool

  2. Change from baseline skill confidence

    Time frame: Baseline, 1 month post-implementation

    Self-reported level of confidence on investigating HAI clusters

  3. Usability score

    Time frame: Immediately post training, 1 month post-implementation

    System Usability Scale score, and impacts of the tool on work and workflow (interruptions, workarounds, issues/challenges)

  4. GeoHAI Use

    Time frame: 1 month post-implementation

    Self-reported frequency of use of the GeoHAI tool

  5. Change in Healthcare-Associated Infection (HAI) Investigation Process

    Time frame: Baseline, 1 month post-implementation

    Change in how infection preventionists investigate Healthcare-Associated Infections (HAIs)

  6. Number of months healthcare system is below goal HAI rate

    Time frame: Baseline, 3 months post-implementation

    Monthly HAI rate at healthcare system level before intervention and after

  7. Change in feasibility score

    Time frame: Immediately post training, 1 month post-implementation

    Score on feasibility, acceptability, and appropriateness domains of validated Implementation Outcome scale (minimum score = 1, maximum score = 5, where higher scores indicate better feasibility)

  8. Change in time to HAI cluster identification

    Time frame: Baseline, 3 months post-implementation

    Time from when an HAI test was ordered for the first positive patient ultimately contained in an identified HAI cluster, to when that HAI cluster is identified.

Sponsors and collaborators

Lead sponsor

Ohio State University

Other

Collaborators

  • Agency for Healthcare Research and Quality (AHRQ)
  • University of Florida

Registry information

Official study title

GeoHAI Implementation in IP Workflow

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Nov 10, 2022
Registry last updated
May 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.